Document is current
Any future updates will be listed below
-
Authors
Zhou, Yongxin
Wang, Haiyan
Lu, Dianyu
Jiang, Tao
Huang, Zhanpeng
Wang, Feixiang
Yao, Yonghua
Gu, Yu
Wei, Wei
-
Funding
Funding for this research was provided by:
the joint project by Guangzhou City and Guangzhou Medical University (SL2022A030)
Guangdong Provincial Medical Science and Technology Foundation (B2023055)
- License Information
-
More Information
Article History
Received: 20 October 2024
Accepted: 17 February 2025
First Online: 13 March 2025
Declarations
:
: This study was approved by the Institutional Review Boards of the Guangzhou Institute of Cancer Research, the Affiliated Cancer Hospital, Guangzhou Medical University (IRB number 202111ZN), and the second Affiliated Hospital of Guangzhou University of Chinese Medicine (IRB number 202220001). Written informed consent was obtained from all patients. This prospective cohort study was registered with the Chinese Clinical Trial Registry as ChiCTR2100051170.
: Consent for publication was obtained from all authors.
: The authors declare no competing interests.
